<?xml version="1.0" encoding="UTF-8"?>
<p id="p0386" num="0386" sourceFile="EP 1828185B1.xml">In a manner analogous to 
  <b>Example 66</b>, 91 mg of the title compound was synthesized from from 100 mg (0.25 mmol) of 4-[2-(3-aminophenyl)pyrazolo[1,5-a]pyridin-3-yl]-
  <i>N-</i>(3-fluorophenyl)-2-pyrimidinamine and 46 mg (0.353 mmol) of 5-isoxazolecarbonyl chloride a yellow solid: 
  <sup>1</sup>H NMR (d
  <sub>6</sub>-DMSO, 400 MHz) δ 6.59 (d, 1H, J = 5.5 Hz), 6.72 (td, 1H, J = 8.0 and 2.5 Hz), 7.14 (td, 1H, J = 6.8 and 1.5 Hz), 7.21-7.29 (m, 2H), 7.37-7.53 (m, 4H), 7.78 (d, 1H, J = 12.3 Hz), 7.93 (d, 1H, J = 8.6 Hz), 8.09 (s, 1 H), 8.32 (d, 1H, J = 5.4 Hz), 8.49 (d, 1 H, J = 8.8 Hz), 8.81 (d, 1 H, J = 1.7 Hz), 8.86 (d, 1 H, J = 6.8 Hz), 9.81 (s, 1 H), and 10.87 (s, 1 H); HRMS calcd for C
  <sub>27</sub>H
  <sub>18</sub>FN
  <sub>7</sub>O
  <sub>2</sub>: 491.1506, found: 492.1583 (M+H
  <sup>+</sup>).
</p>
